SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for AGENUS INC (AGEN) (CIK 0001098972) (AGEN) — Jun 15, 2016

AGENUS INC (AGEN) (CIK 0001098972)
Date: June 15, 2016 · CIK: 0001098972 · Accession: 0000000000-16-080613

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
April 15, 2016
Author
/s/ Mary Beth Breslin for
Form
UPLOAD
Company
AGENUS INC (AGEN) (CIK 0001098972)

Letter

June 1 5, 2016 Garo H. Armen Chief Executive Officer Agenus Inc. 3 Forbes Road Lexington, MA 02421

Re: Agenus Inc. Preliminary Proxy Statement on Schedule 14A Filed April 15, 2016 File No. 000 -29089

Dear Mr. Armen :

We completed our review of your filing on April 26, 2016. We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Mary Beth Breslin for

Show Raw Text
June 1 5, 2016

Garo H. Armen
Chief Executive Officer
Agenus Inc.
3 Forbes Road
Lexington, MA 02421

Re: Agenus Inc.
 Preliminary Proxy Statement on Schedule 14A
Filed April 15, 2016
File No. 000 -29089

Dear Mr. Armen :

We completed our review of your filing on April 26, 2016.   We remind you that our
comments or changes to disclosure in response to our comments do not foreclose  the
Commission from taking any action with respect to the company or the filing and the company
may not assert staff comments as a defense in any proceeding initiated by the Commission or any
person under the federal securities laws of the United States.  We urge all persons who are
responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the
filing includes the information the Securities Exchange Act of 1934 and all applicable rules
require.

Sincerely,

 /s/ Mary Beth Breslin for

Suzanne Haye s
Assistant Director
Office of Healthcare and Insurance

cc: Zachary R. Blume
Ropes & Gray LLP